Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Efthymiou

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Swiss Medical Weekly|March 25, 2025
VEXAS syndrome: a Swiss national retrospective cohort studyLouis Wolff, Leo Caratsch, Fabian Lötscher, et al.
Hemasphere|June 24, 2022
Real-world Data From the Swiss Lenalidomide in MDS del(5q) (SLIM)-Registry Identify New Chances and Challenges in Lenalidomide Treatment of Patients With MDS del(5q)Axel Rüfer, Hubert Angermann, Rudolf Benz, et al.
Cancers|February 10, 2021
Inferior Outcome of Addition of the Aminopeptidase Inhibitor Tosedostat to Standard Intensive Treatment for Elderly Patients with AML and High Risk MDSJeroen Janssen, Bob Löwenberg, Markus Manz, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Swiss Medical Weekly|March 25, 2025
VEXAS syndrome: a Swiss national retrospective cohort studyLouis Wolff, Leo Caratsch, Fabian Lötscher, et al.
Hemasphere|June 24, 2022
Real-world Data From the Swiss Lenalidomide in MDS del(5q) (SLIM)-Registry Identify New Chances and Challenges in Lenalidomide Treatment of Patients With MDS del(5q)Axel Rüfer, Hubert Angermann, Rudolf Benz, et al.
Cancers|February 10, 2021
Inferior Outcome of Addition of the Aminopeptidase Inhibitor Tosedostat to Standard Intensive Treatment for Elderly Patients with AML and High Risk MDSJeroen Janssen, Bob Löwenberg, Markus Manz, et al.
Pageof 2